
Validea's guru fundamental report rates Costco (COST) highly with a 79% score under its Warren Buffett-inspired 'Patient Investor' model, which prioritizes predictable profitability, low debt, and reasonable valuations. While COST demonstrated strength across key fundamentals like earnings predictability, debt service, and free cash flow, its 79% rating falls just shy of the 80% threshold for 'some interest,' notably failing the 'Initial Rate of Return' test. This indicates COST aligns well with Buffett's long-term investment principles but presents a valuation consideration for investors.
Costco Wholesale Corp (COST) scores a 79% on Validea's Patient Investor model, which emulates Warren Buffett's strategy, indicating a strong but not unequivocally compelling investment case. This score is just shy of the 80% threshold that typically signals definite interest. The company's strength is rooted in its fundamentals, passing critical tests for earnings predictability, debt service, return on equity, return on total capital, and free cash flow generation. Furthermore, COST demonstrates effective capital management by passing criteria for its use of retained earnings and share repurchase programs. The single point of failure is the 'Initial Rate of Return' test, which suggests that despite the company's high quality and positive long-term expected returns, its current stock valuation may be too high to provide a compelling entry point for a value-oriented investor following this specific model.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.65
Ticker Sentiment